BioPharm International
December 01, 2014
From the Editor
27
12
Industry professionals share the ups and downs of working in the biopharma industry.
December 01, 2014
Regulatory Beat
27
12
Operational changes at FDA and CDER aim to improve global market monitoring.
December 01, 2014
Perspectives on Outsourcing
27
12
Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.
December 01, 2014
Features
27
12
MedicalRF.com/Science Photo Library-ANDRZEJ WOJCICKI/Henrik Jonsson/Stocktrek Images; Dan Ward
December 01, 2014
Features
27
12
Biopharma employees report gains in compensation and job satisfaction, as industry growth continues.
December 01, 2014
Peer-Reviewed Research
27
12
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
December 01, 2014
Quality Management
27
12
The author proposes a quality management system that uses the power of executive management to promote a positive quality culture.
December 01, 2014
Troubleshooting
27
12
Performing degradation studies is the best strategy to evaluate toxicity risk.
December 01, 2014
Products
27
12
Tosoh Bioscience’s CaPure-HA hydroxyapatite chromatography resin is designed for the purification of monoclonal antibodies, polyclonal antibodies, and antibody fragments, and the separation of antibody isoforms and isozymes.
December 01, 2014
Issue PDF
27
12
Click the title above to open the BioPharm International December 2014 issue in an interactive PDF format.